The retatrutide dosing schedule after high-dose tirzepatide accounts for existing GLP-1 and GIP receptor adaptation while introducing glucagon receptor agonism gradually
Total peptide loading per vial: 70 mg
Through rigorous refinement, weve achieved a 100% pure GHK-Cu peptide that surpasses cosmetic-grade purity (95%) and even pharmaceutical standards (98.5%), setting a new industry benchmark in both quality and its unmistakable blue hue
10.15252/emmm.201606210 EMBO Mol
[7-11] Dual GLP-1 and glucagon receptor agonists, including cotadutide, efinopegdutide and pemvidutide, show varying efficacy in type 2 diabetes, obesity and non-alcoholic steatohepatitis, likely due to differing GLP-1/glucagon activation
doi: 10.1016/j.expneurol.2019.113061 191 SpenceRDHambyMEUmedaEItohNDuSWisdomAJet al